Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

Published Date: 18 Oct 2024

May become "treatment of choice" over brentuximab vedotin for all disease stages

Read Full News

Latest News

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...

The New Perfectionism Problem in Medical Training

The profession has always attracted perfectionists. Experts worry a more fear-based version of the trait could affect both doctors and patients.

Committee Recommends Canada Not Permit Euthanasia Solely for Mental Illness

Euthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

The U.S. Food and Drug Administration has declined to approve Achieve Life Sciences' drug to treat nicotine dependence in adults, ⁠citing unresolved issues found at a...
HTTP error: 503HTTP error: 503HTTP error: 503

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

News All Time

AACR: American Association for Cancer Research

HTTP error: 503HTTP error: 503

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

All 20 smoldering myeloma patients had deep responses after one-time infusion
HTTP error: 503

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

Approach could help patients avoid often debilitating surgeries, early study suggests
HTTP error: 503

More Positive Survival Data in Lung Cancer With Perioperative Therapy

High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly OS

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Several justices seemed sympathetic to Monsanto's argument that it can't be sued under state law

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

News, features, and commentary about cancer-related issues
HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503HTTP error: 503

Recommended News For You

Report provides global picture of wide inequalities in care for women's cancers

Food insecurity linked to tumor growth in pediatric neuroblastoma

Alkem introduces cetuximab under the trade name Cetuxa in India.

Large, Grade 4 Kidney Tumors Pose Risk of Early Cancer-Specific Mortality

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Watch for Psoriasis After Cancer Immunotherapy, Study Says

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

Recommended Articles For You

Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors 

Beyond the Organs: Navigating the Era of Tissue-Agnostic Therapies in Modern Cancer Management 

Abemaciclib in Combination with Therapies for Patients with Metastatic Breast Cancer 

Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

2.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

3.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

4.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

5.

A radiotheranostic approach designed to combat aggressive cancers

1.

Oncolytic Vaccinia Virus Immunotherapy: A New Frontier in GI Cancer Treatment

2.

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies

3.

What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment

4.

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results

5.

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

2.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

4.

Oropharyngeal Cancer in Relation to HPV Status

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot